rs28929470

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4_StrongBS2_Supporting

The NM_000295.5(SERPINA1):​c.739C>T​(p.Arg247Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00307 in 1,614,004 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0020 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0032 ( 5 hom. )

Consequence

SERPINA1
NM_000295.5 missense

Scores

4
7
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:4U:8B:1O:1

Conservation

PhyloP100: 2.29
Variant links:
Genes affected
SERPINA1 (HGNC:8941): (serpin family A member 1) The protein encoded by this gene is a serine protease inhibitor belonging to the serpin superfamily whose targets include elastase, plasmin, thrombin, trypsin, chymotrypsin, and plasminogen activator. This protein is produced in the liver, the bone marrow, by lymphocytic and monocytic cells in lymphoid tissue, and by the Paneth cells of the gut. Defects in this gene are associated with chronic obstructive pulmonary disease, emphysema, and chronic liver disease. Several transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.029084444).
BS2
High Homozygotes in GnomAdExome4 at 5 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SERPINA1NM_000295.5 linkuse as main transcriptc.739C>T p.Arg247Cys missense_variant 3/5 ENST00000393087.9 NP_000286.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SERPINA1ENST00000393087.9 linkuse as main transcriptc.739C>T p.Arg247Cys missense_variant 3/51 NM_000295.5 ENSP00000376802 P1P01009-1

Frequencies

GnomAD3 genomes
AF:
0.00197
AC:
300
AN:
152020
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000894
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000661
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00362
Gnomad OTH
AF:
0.000957
GnomAD3 exomes
AF:
0.00212
AC:
533
AN:
251358
Hom.:
1
AF XY:
0.00214
AC XY:
291
AN XY:
135844
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.000397
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000508
Gnomad NFE exome
AF:
0.00428
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.00319
AC:
4658
AN:
1461866
Hom.:
5
Cov.:
31
AF XY:
0.00310
AC XY:
2255
AN XY:
727228
show subpopulations
Gnomad4 AFR exome
AF:
0.000478
Gnomad4 AMR exome
AF:
0.000179
Gnomad4 ASJ exome
AF:
0.000344
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.000562
Gnomad4 NFE exome
AF:
0.00404
Gnomad4 OTH exome
AF:
0.00162
GnomAD4 genome
AF:
0.00197
AC:
299
AN:
152138
Hom.:
1
Cov.:
32
AF XY:
0.00173
AC XY:
129
AN XY:
74364
show subpopulations
Gnomad4 AFR
AF:
0.000867
Gnomad4 AMR
AF:
0.000392
Gnomad4 ASJ
AF:
0.000576
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000661
Gnomad4 NFE
AF:
0.00362
Gnomad4 OTH
AF:
0.000947
Alfa
AF:
0.00294
Hom.:
3
Bravo
AF:
0.00195
TwinsUK
AF:
0.00512
AC:
19
ALSPAC
AF:
0.00571
AC:
22
ESP6500AA
AF:
0.00113
AC:
5
ESP6500EA
AF:
0.00407
AC:
35
ExAC
AF:
0.00287
AC:
349
EpiCase
AF:
0.00278
EpiControl
AF:
0.00279

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:4Uncertain:8Benign:1Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Alpha-1-antitrypsin deficiency Pathogenic:3Uncertain:3Benign:1
Likely pathogenic, no assertion criteria providedclinical testingDepartment of Laboratory Medicine and Genetics, Trillium Health Partners Credit Valley HospitalDec 08, 2014Mildly reduced alpha-1-antitrypsin activity. In practice appears to be associated with mild deficiency. Literature opinion divided. Protein levels may be normal but has a decreased ability to inhibit neutrophil elastase & is frequently seen in patients with respiratory symptoms. -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Uncertain significance, no assertion criteria providedresearchCSER _CC_NCGL, University of WashingtonJun 01, 2014- -
Pathogenic, no assertion criteria providedliterature onlyGeneReviewsMay 01, 2014- -
Uncertain significance, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Likely pathogenic, criteria provided, single submitterclinical testingMGZ Medical Genetics CenterApr 11, 2022- -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 24, 2022This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 247 of the SERPINA1 protein (p.Arg247Cys). This variant is present in population databases (rs28929470, gnomAD 0.4%). This missense change has been observed in individual(s) with chronic obstructive pulmonary disease (COPD) and slight decreased A1AT protein levels and alpha 1-antitrypsine (A1AT) deficiency (PMID: 2035534, 22078084). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as allele F or p.Arg223Cys. ClinVar contains an entry for this variant (Variation ID: 17961). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SERPINA1 protein function. Experimental studies have shown that this missense change affects SERPINA1 function (PMID: 8912354). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Pathogenic:1Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingGeneDxNov 28, 2023Commonly referred to as the F variant or R223C by alternate nomenclature, and has been reported multiple times in association with normal serum AAT levels when present in the homozygous state and mildly reduced AAT levels when present with another disease-causing SERPINA1 variant (PMID: 2035534, 22078084, 25098359); Homozygosity for R247C may increase susceptibility to elastase-induced lung damage but not emphysema, whereas this variant can be of clinical consequence when in the compound heterozygous state with the Z allele (E366K) (PMID: 25098359); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25525159, 18682522, 26987331, 24713750, 8912354, 25637381, 24082139, 27153395, 22078084, 2035534, 9041988, 15115878, 29882371, 26310624, 23632999, 6306478, Wang2022[Functional Study], 20301692, 31819391, 32181528, 31450843, 26647313, 31661293, 35477570, 37622442, 25098359) -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 30, 2018- -
Pathogenic, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicOct 05, 2022- -
SERPINA1-related disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesSep 09, 2024The SERPINA1 c.739C>T variant is predicted to result in the amino acid substitution p.Arg247Cys. This variant has been reported in the literature, but its pathogenicity was not fully understood (Supplementary Table 1 at Amendola et al. 2015. PubMed ID: 25637381; Table S5 at Maxwell et al. 2016. PubMed ID: 27153395). This variant is also known as the F allele or p.Arg223Cys, and is reported to have decreased binding affinity and inhibitory capacity against elastase resulting in lung but not liver disease (Giacopuzzi et al. 2018. PubMed ID: 29882371). This variant is reported in 0.42% of alleles in individuals of European (Non-Finnish) descent), including one homozygous observation. In summary, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineOct 11, 2013The Arg247Cys variant in SERPINA1, also called the F allele, has been identified in 0.4% (35/8600) of European American chromosomes from a large population by t he NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/). This vari ant has been reported to affect protein function (Cook 1996) and may contribute to disease when homozygous or when present with other SERPINA1 variants (Ringenb ach 2011). Computational analyses (biochemical amino acid properties, AlignGVGD, PolyPhen2, and SIFT) also support an impact to the protein though their accurac y is not known. In summary, additional information is needed to fully assess the clinical significance of this variant. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 17, 2017- -
PI F Other:1
other, no assertion criteria providedliterature onlyOMIMJul 15, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
0.0064
T
BayesDel_noAF
Pathogenic
0.24
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.56
D;D;D;D;D;D;D;D;D;.
Eigen
Benign
-0.016
Eigen_PC
Benign
-0.19
FATHMM_MKL
Benign
0.52
D
LIST_S2
Uncertain
0.90
.;.;.;D;.;.;.;.;.;D
M_CAP
Uncertain
0.094
D
MetaRNN
Benign
0.029
T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.19
D
MutationAssessor
Pathogenic
3.7
H;H;H;H;H;H;H;H;H;H
MutationTaster
Benign
0.90
N;N;N;N;N;N;N;N;N
PrimateAI
Benign
0.31
T
PROVEAN
Pathogenic
-6.7
D;D;D;D;D;.;D;D;D;D
REVEL
Uncertain
0.60
Sift
Uncertain
0.0010
D;D;D;D;D;.;D;D;D;D
Sift4G
Pathogenic
0.0010
D;D;D;D;D;.;D;D;D;D
Polyphen
0.99
D;D;D;D;D;D;D;D;D;P
Vest4
0.86
MVP
0.93
MPC
0.17
ClinPred
0.13
T
GERP RS
4.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.52
gMVP
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs28929470; hg19: chr14-94847386; COSMIC: COSV63345392; COSMIC: COSV63345392; API